Conditions: Leukemia
Intervention Type: Biological
Intervention Names
The following are clinical trials from the Healia Clinical Trials Information Database related to "Leukemia" that are researching the effect of "Biological" interventions organized by the name of the intervention.
- Leukemia - Biological - sargramostim (11 documents)
- Leukemia - Biological - rituximab (6 documents)
- Leukemia - Biological - aldesleukin (4 documents)
- Leukemia - Biological - LMB-2 immunotoxin (3 documents)
- Leukemia - Biological - epoetin alfa (3 documents)
- Leukemia - Biological - alemtuzumab (2 documents)
- Leukemia - Biological - allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes (2 documents)
- Leukemia - Biological - apolizumab (2 documents)
- Leukemia - Biological - bevacizumab (2 documents)
- Leukemia - Biological - denileukin diftitox (2 documents)
- Leukemia - Biological - etanercept (2 documents)
- Leukemia - Biological - lintuzumab (2 documents)
- Leukemia - Biological - monoclonal antibody Mik-beta-1 (2 documents)
- Leukemia - Biological - peripheral blood lymphocyte therapy (2 documents)
- Leukemia - Biological - recombinant interleukin-12 (2 documents)
- Leukemia - Biological - therapeutic allogeneic lymphocytes (2 documents)
- Leukemia - Biological - 4 x 10e6 CD34+ cells per kg (1 documents)
- Leukemia - Biological - Aldesleukin (1 documents)
- Leukemia - Biological - AlloStim (1 documents)
- Leukemia - Biological - Autologous Dendritic Cells (1 documents)
- Leukemia - Biological - B43-genistein immunoconjugate (1 documents)
- Leukemia - Biological - BL22 immunotoxin (1 documents)
- Leukemia - Biological - DTGM fusion protein (1 documents)
- Leukemia - Biological - Donor lymphocytes (1 documents)
- Leukemia - Biological - Genetically modified T cells (1 documents)
- Leukemia - Biological - Granulocyte-colony stimulating factor (1 documents)
- Leukemia - Biological - Hematopoietic Stem Cell Transplant (HSCT) (1 documents)
- Leukemia - Biological - IL-2 AND HUMAN CD40 LIGAND PLASMID GENE MODIFIED AUTOLOGOUS TUMOR CELLS (1 documents)
- Leukemia - Biological - NK Cell Infusion (1 documents)
- Leukemia - Biological - NK-92 cells (1 documents)
- Leukemia - Biological - NK-Cell Infusion (1 documents)
- Leukemia - Biological - NK-DLI Infusions (1 documents)
- Leukemia - Biological - PR-1 vaccine (1 documents)
- Leukemia - Biological - Peripheral blood stem cell transplantation (1 documents)
- Leukemia - Biological - Pneumococcal Vaccine (1 documents)
- Leukemia - Biological - Rituximab (1 documents)
- Leukemia - Biological - Sargramostim (1 documents)
- Leukemia - Biological - T Cell-Depleted Hematopoietic Stem Cell Transplantation (1 documents)
- Leukemia - Biological - Tumor Vaccine: CD40 LIGAND AND IL-2 GENE MODIFIED AUTOLOGOUS SKIN FIBROBLASTS AND TUMOR CELLS (1 documents)
- Leukemia - Biological - Umbilical Cord Blood Transplantation After Reduced-Intensity Conditioning (1 documents)
- Leukemia - Biological - Unmanipulated UCB Unit (1 documents)
- Leukemia - Biological - WT-1 (1 documents)
- Leukemia - Biological - WT1-sensitized T cells (1 documents)
- Leukemia - Biological - autologous Epstein-Barr virus-specific cytotoxic T lymphocytes (1 documents)
- Leukemia - Biological - autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine (1 documents)
- Leukemia - Biological - autologous tumor cell vaccine (1 documents)
- Leukemia - Biological - bcr-abl peptide vaccine (1 documents)
- Leukemia - Biological - bystander vaccine (1 documents)
- Leukemia - Biological - daclizumab (1 documents)
- Leukemia - Biological - deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins (1 documents)
- Leukemia - Biological - donor lymphocytes (1 documents)
- Leukemia - Biological - eculizumab (1 documents)
- Leukemia - Biological - filgrastim (1 documents)
- Leukemia - Biological - gemtuzumab ozogamicin (1 documents)
- Leukemia - Biological - gene-modified T cells targeted to B-ALL tumor cells (1 documents)
- Leukemia - Biological - human myeloid progenitor cells (1 documents)
- Leukemia - Biological - ipilimumab (1 documents)
- Leukemia - Biological - lumiliximab (1 documents)
- Leukemia - Biological - monoclonal antibody E2.3 (1 documents)
- Leukemia - Biological - recombinant 70-kD heat-shock protein (1 documents)
- Leukemia - Biological - recombinant flt3 ligand (1 documents)
- Leukemia - Biological - recombinant human mannose-binding lectin (1 documents)
- Leukemia - Biological - recombinant interferon alfa (1 documents)
- Leukemia - Biological - siplizumab (1 documents)
- Leukemia - Biological - tetanus toxoid (1 documents)
- Leukemia - Biological - therapeutic autologous dendritic cells (1 documents)
- Leukemia - Biological - thymoglobulin (1 documents)
- Leukemia - Biological - trivalent influenza vaccine (1 documents)
